eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Ann - Comment

Ann - Comment

Document ID: FDA-2011-N-0599-0006
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: January 23 2012, at 12:00 AM Eastern Standard Time
Date Posted: February 14 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: November 16 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: April 25 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 80fa1459
View Document:  View as format xml

View Comment

I am an allergy nurse and I work for an Otolaryncologist. We see many patients with sinus disease that is aggravated by inhalant allergies. Most have been helped by immonotherapy, and can survive the season changes. I feel it would be a great disservice to these people to remove Non-Standardized Allergenic extracts from the market. Many sinus infections are caused by molds and with mold immunotherapy I have patients who have been free of sinus infections for years!! Many of our patients can not take part in normal family outings due to pollens, dust, animals, and molds. After being desensitized they are able to take part in these family activities.

Related Comments

    View All
Total: 33
Roger James Simpson - Comment
Public Submission    Posted: 11/23/2011     ID: FDA-2011-N-0599-0005

Apr 25,2012 11:59 PM ET
Ann - Comment
Public Submission    Posted: 02/14/2012     ID: FDA-2011-N-0599-0006

Apr 25,2012 11:59 PM ET
Jeffrey G Bennion - Comment
Public Submission    Posted: 02/14/2012     ID: FDA-2011-N-0599-0007

Apr 25,2012 11:59 PM ET
Paul Foster - Comment
Public Submission    Posted: 02/28/2012     ID: FDA-2011-N-0599-0008

Apr 25,2012 11:59 PM ET
Gerald D Natzke - Comment
Public Submission    Posted: 02/28/2012     ID: FDA-2011-N-0599-0009

Apr 25,2012 11:59 PM ET